Study: Can a Probiotic Reduce Colitis Severity?

Earlier research had established that removing LTA from a probiotic changes how the gut's immune system responds — shifting it from pro-inflammatory toward regulatory. This 2012 study published in Immunotherapy by Khan and colleagues pushed that finding further. They tested whether the LTA-deficient strain NCK2025 could not only prevent gut inflammation from escalating, but reduce it once already established.

What Did the Study Test?

The research used animal models with experimentally induced colitis — gut inflammation severe enough to model the kind of mucosal damage seen in inflammatory bowel conditions. Two distinct types of induced colitis were tested. In both, the researchers measured whether NCK2025 produced meaningful reductions in inflammation.

The result: NCK2025 effectively reduced colitis severity in both models. More significantly, it also reduced inflammation in animals where colitis had already been established before treatment began — not just prevented, but actively resolved.

How Does NCK2025 Calm Existing Inflammation?

The mechanism the study identified runs through a regulatory system the gut already has built in — NCK2025 activates it rather than bypassing it.

When NCK2025 reaches gut tissue, it prompts dendritic cells and macrophages — immune cells that patrol the gut lining — to produce more IL-10, an anti-inflammatory signaling molecule. That increase in IL-10 drives an increase in regulatory dendritic cells. Those regulatory dendritic cells then directly activate a specialized immune cell called a FoxP3+ regulatory T-cell, or Treg.

Tregs are the gut immune system's brakes. Their specific function is to recognize when an immune response has gone too far and suppress it. By activating Tregs, NCK2025 doesn't just remove a trigger — it engages the mechanism the gut uses to resolve inflammation on its own.

Why Does It Matter That Inflammation Was Already Established?

Most probiotic research tests whether a strain prevents a problem in a healthy system. This study tested whether NCK2025 could address inflammation that had already set in — a more meaningful question for anyone currently living with IBS or chronic gut inflammation, not trying to avoid it in the future.

The research found that it could. The mechanism — engaging the gut's own Treg-based regulatory system rather than simply removing a stimulus — offers a targeted approach to calming intestinal immune responses in tissue that is already inflamed.

Read the full study →